Search Results - "NAGATA, Naruhiko"

Carbon Dioxide (CO2 ) vs Iodinated Contrast Digital Subtraction Angiography during Balloon-occluded Retrograde Transvenous Obliteration (BRTO) Using Foam Sclerosant for Gastric Varices by Koizumi, Jun, MD, PhD, Hashimoto, Takeshi, MD, Myojin, Kazunori, MD, PhD, Itou, Chihiro, MD, Hara, Takuya, MD, Sekiguchi, Tatsuya, MD, Ichikawa, Tamaki, MD, PhD, Imai, Yutaka, MD, Kagawa, Tatehiro, MD, PhD, Nagata, Naruhiko, MD, PhD, Watanabe, Norihito, MD, PhD, Mine, Tetsuya, MD, PhD, Nishibe, Toshiya, MD, PhD, Saguchi, Toru, MD, PhD, Janne d'Othée, Bertrand

“…Abstract Purpose To compare the visualization of the target gastric varices (GV) on balloon-occluded retrograde transvenous venography (BRTV) using iodinated…”
Get full text

Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma by Kagawa, Tatehiro, Koizumi, Jun, Kojima, Sei‐ichiro, Nagata, Naruhiko, Numata, Makoto, Watanabe, Norihito, Watanabe, Tetsu, Mine, Tetsuya

“…BACKGROUND: Radiofrequency ablation (RFA) is becoming a well‐known local therapy for hepatocellular carcinoma (HCC). Transcatheter arterial chemoembolization…”
Get full text

TYPE 1 GASTRIC CANCER PRESENTING AS PROTEIN-LOSING GASTROENTEROPATHY AND BALL-VALVE SYNDROME by HIROSE, SHUNJI, KAGAWA, TATEHIRO, SHIRAISHI, KOICHI, NAGATA, NARUHIKO, OKADA, KAZUTAKE, TAJIMA, TAKAYUKI, MUKAI, MASAYA, SEKIDO, YASUTOMO, MINE, TETSUYA

Get full text

Weight-based high- and low-dose ribavirin in combination with peginterferon α-2b therapy for genotype 2 chronic hepatitis C: A randomized trial by Kagawa, Tatehiro, Kojima, Sei-ichiro, Shiraishi, Koichi, Takashimizu, Shinji, Nagata, Naruhiko, Shiozawa, Hirokazu, Nishizaki, Yasuhiro, Ikeda, Akihiko, Tei, Yoshihiro, Atsukawa, Kazuhiro, Kamochi, Jun-ichiro, Wasada, Mitsuru, Numata, Makoto, Arase, Yoshitaka, Hirose, Shunji, Yamada, Takuji, Hata, Yasuo, Watanabe, Norihito, Morizane, Toshio, Mine, Tetsuya

“…Aim:  The optimal ribavirin dose in the treatment of patients infected with hepatitis C virus (HCV) genotype 2 remains to be elucidated. We aimed to seek the…”
Get full text

Meloxicam as an adjuvant to peginterferon-α-2a and ribavirin treatment for genotype 1 chronic hepatitis C: A randomized trial by Kagawa, Tatehiro, Kojima, Sei-ichiro, Shiraishi, Koichi, Hirose, Shunji, Arase, Yoshitaka, Takashimizu, Shinji, Watanabe, Norihito, Nagata, Naruhiko, Numata, Makoto, Shiozawa, Hirokazu, Nishizaki, Yasuhiro, Toki, Mayu, Sugita, Teruji, Nomura, Kijuro, Sakaguchi, Takashi, Atsukawa, Kazuhiro, Tajima, Hiroto, Tei, Yoshihiro, Inomoto, Tsutomu, Mine, Tetsuya

“…Aim In this multicenter, randomized trial, we evaluated the effectiveness of meloxicam – a non‐steroidal anti‐inflammatory drug – as an adjuvant for enhancing…”
Get full text

Taurolithocholate impairs bile canalicular motility and canalicular bile secretion in isolated rat hepatocyte couplets by Watanabe, Norihito, Kagawa, Tatehiro, Kojima, Seiichiro, Takashimizu, Shinji, Nagata, Naruhiko, Nishizaki, Yasuhiro, Mine, Tetsuya

“…AIM To investigate the effects of taurolithocholate （TLC） on the canalicular motility in isolated rat hepatocyte couplets （IRHC）. METHODS： TLC was added to…”
Get full text

Eight-week oral administration of meloxicam, a non-steroidal anti-inflammatory drug, prevents dose reduction of pegylated interferon α-2a in the treatment of chronic hepatitis C by Kagawa, Tatehiro, Shiozawa, Hirokazu, Kojima, Sei-ichiro, Takashimizu, Shinji, Nagata, Naruhiko, Numata, Makoto, Morino, Fumitoshi, Nishizaki, Yasuhiro, Mochizuki, Kaori, Watanabe, Norihito, Watanabe, Tetsu, Matsuzaki, Shohei, Mine, Tetsuya

“…Aim:  We conducted a trial to evaluate whether eight‐week oral administration of meloxicam, a non‐steroidal anti‐inflammatory drug, would decrease the rate of…”
Get full text

The Chemistry and Biological Effects of Malondialdehyde-Acetaldehyde Adducts by Thiele, Geoffrey M., Worrall, Simon, Tuma, Dean J., Klassen, Lynell W., Wyatt, Todd A., Nagata, Naruhiko

“…This article represents the proceedings of a workshop at the 2000 ISBRA Meeting in Yokohama, Japan. The chairs were Geoffrey M. Thiele and Simon Worrall. The…”
Get full text

Effect of in vitro interferon-beta administration on hepatitis C virus in peripheral blood mononuclear cells as a predictive marker of clinical response to interferon treatment for chronic hepatitis C by Mochizuki, Kaori, Kagawa, Tatehiro, Takashimizu, Shinji, Kawazoe, Kazuya, Kojima, Sei-Ichiro, Nagata, Naruhiko, Nakano, Atsushi, Nishizaki, Yasuhiro, Shiraishi, Koichi, Itakura, Masaru, Watanabe, Norihito, Mine, Tetsuya, Matsuzaki, Shohei

“…AIM:To test whether in vitro incubation of peripheral blood mononuclear cells (PBMC) with interferon (IFN) could efficiently decrease hepatitis C virus-RNA…”
Get full text

A liver-derived immunosuppressive factor is an arginase: identification and mechanism of immunosuppression by OHTANI, Yasuo, HIYOSHI, Mineyoshi, OHKUBO, Tomoichi, TSUJI, Kimiyoshi, HAGIHARA, Masao, NAKASAKI, Hisao, MAKUUCHI, Hiroyasu, NAGATA, Naruhiko, MINE, Tetsuya, TAKADA, Shigeo, YAMAMURA, Masaichi, TSUDA, Michio

“…We found a substance in culture medium of neonatal pig liver fragments, which suppresses an immune response monitored by 3H-thymidine incorporation using…”
Get full text

Differential Impact of Adherence to Pegylated Interferon and Ribavirin in the Treatment of Genotype 1 High Viral Titer Chronic Hepatitis C by Shiraishi, Koichi, Nagata, Naruhiko, Hirose, Shunji, Kojima, Sei-ichiro, Kagawa, Tatehiro, Numata, Makoto, Watanabe, Norihito, Shiozawa, Hirokazu, Nishizaki, Yasuhiro, Motegi, Shigeyuki, Takashimizu, Shinji, Kamochi, Jun-ichiro, Wasada, Mitsuru, Ohno, Takashi, Tei, Yoshihiro, Nakano, Atsushi, Yamada, Takuji, Atsukawa, Kazuhiro, Watanabe, Tetsu, Mine, Tetsuya

“…To clarify the impact of adherence, we treated 122 genotype 1 high viral titer chronic hepatitis C patients with pegylated interferon (peg-IFN) and ribavirin…”
Get full text

Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation Therapy for Early Stage Hepatocellular Carcinoma: Comparison With Surgical Resection by KAGAWA, Tatehiro, KOIZUMI, Jun, KOJIMA, Sei-Ichiro, NAGATA, Naruhiko, NUMATA, Makoto, WATANABE, Norihito, WATANABE, Tetsu, MINE, Tetsuya

“…Radiofrequency ablation (RFA) is becoming a well-known local therapy for hepatocellular carcinoma (HCC). Transcatheter arterial chemoembolization (TACE) is…”
Get full text

Off-treatment durability of antiviral response to nucleoside analogues in patients with chronic hepatitis B by Nagata, Naruhiko, Kagawa, Tatehiro, Hirose, Shunji, Arase, Yoshitaka, Tsuruya, Kota, Anzai, Kazuya, Shiraishi, Koichi, Mine, Tetsuya

“…Off-treatment durability of nucleoside analogue (NA) therapy in patients with chronic hepatitis B has not been well investigated. In this study we monitored…”
Get full text

Meloxicam as an adjuvant to peginterferon- alpha -2a and ribavirin treatment for genotype 1 chronic hepatitis C: A randomized trial by Kagawa, Tatehiro, Kojima, Sei-ichiro, Shiraishi, Koichi, Hirose, Shunji, Arase, Yoshitaka, Takashimizu, Shinji, Watanabe, Norihito, Nagata, Naruhiko, Numata, Makoto, Shiozawa, Hirokazu, Nishizaki, Yasuhiro, Toki, Mayu, Sugita, Teruji, Nomura, Kijuro, Sakaguchi, Takashi, Atsukawa, Kazuhiro, Tajima, Hiroto, Tei, Yoshihiro, Inomoto, Tsutomu, Mine, Tetsuya

“…In this multicenter, randomized trial, we evaluated the effectiveness of meloxicam - a non-steroidal anti-inflammatory drug - as an adjuvant for enhancing…”
Get full text

Weight-based high- and low-dose ribavirin in combination with peginterferon alpha -2b therapy for genotype 2 chronic hepatitis C: A randomized trial by Kagawa, Tatehiro, Kojima, Sei-ichiro, Shiraishi, Koichi, Takashimizu, Shinji, Nagata, Naruhiko, Shiozawa, Hirokazu, Nishizaki, Yasuhiro, Ikeda, Akihiko, Tei, Yoshihiro, Atsukawa, Kazuhiro, Kamochi, Jun-ichiro, Wasada, Mitsuru, Numata, Makoto, Arase, Yoshitaka, Hirose, Shunji, Yamada, Takuji, Hata, Yasuo, Watanabe, Norihito, Morizane, Toshio, Mine, Tetsuya

“…Aim: The optimal ribavirin dose in the treatment of patients infected with hepatitis C virus (HCV) genotype 2 remains to be elucidated. We aimed to seek the…”
Get full text

Eight-week oral administration of meloxicam, a non-steroidal anti-inflammatory drug, prevents dose reduction of pegylated interferon alpha-2a in the treatment of chronic hepatitis C by Kagawa, Tatehiro, Shiozawa, Hirokazu, Kojima, Sei-Ichiro, Takashimizu, Shinji, Nagata, Naruhiko, Numata, Makoto, Morino, Fumitoshi, Nishizaki, Yasuhiro, Mochizuki, Kaori, Watanabe, Norihito, Watanabe, Tetsu, Matsuzaki, Shohei, Mine, Tetsuya

“…We conducted a trial to evaluate whether eight-week oral administration of meloxicam, a non-steroidal anti-inflammatory drug, would decrease the rate of the…”
Get full text

Assessment of a difference in ALDH2 heterozygotes and alcoholic liver injury by NAGATA, Naruhiko, HIYOSHI, Mineyoshi, SHIOZAWA, Hirokazu, SHIRAISHI, Koichi, WATANABE, Norihito, TSUDA, Michio, MATSUZAKI, Shohei

“…We have speculated that the degree of liver dysfunction in alcoholic liver disease with ALDH2*1/2*2 may be less pronounced than that with ALDH2*1/2*1. In the…”
Get full text

Clinical and pathological studies on an atypical form of primary biliary cirrhosis by Watanabe, Norihito, Nakano, Atsushi, akashimizu, Shinji, Yamada, Chisato, Nagata, Naruhiko, Watanabe, Mitsuyuki, Shiraishi, Koichi, Matsuzaki, Shohei

Get full text

Assessment of a Difference in ALDH2 Heterozygotes and Alcoholic Liver Injury by Nagata, Naruhiko, Hiyoshi, Mineyoshi, Shiozawa, Hirokazu, Shiraishi, Koichi, Watanabe, Norihito, Tsuda, Michio, Matsuzaki, Shohei

“…We have speculated that the degree of liver dysfunction in alcoholic liver disease with ALDH2*1/2*2 may be less pronounced than that with ALDH2*1/2*1. In the…”
Get full text

Sonographic evaluation of the anterior liver surface in chronic liver diseases using a 7.5-MHz annular-array transducer: Correlation with laparoscopic and histopathologic findings by Nagata, Naruhiko, Miyachi, Hayato, Nakano, Atsushi, Nanri, Kazuhide, Kobayashi, Hisao, Matsuzaki, Shohei

“…Purpose We studied the sonographic appearance of the anterior liver surface using an ultrasound scanner equipped with a 7.5‐MHz annular‐array transducer to…”
Get full text